medRxiv

🌐 Website: https://www.medrxiv.org
📍 Country: United States
📂 Affiliation: openRxiv (formerly Cold Spring Harbor Laboratory, Yale University, and BMJ)
📚 Area(s) of Study (AOS): Health Sciences – Medicine, Public Health, Epidemiology, Clinical Research, and more

🧠 Introduction

medRxiv (pronounced “med-archive”) is a free, open-access preprint server for the health sciences. Launched in June 2019 as a collaboration between Cold Spring Harbor Laboratory, Yale University, and BMJ, and now operated by the nonprofit openRxiv, medRxiv allows researchers to share complete but unpublished manuscripts across various health-related disciplines. The platform facilitates rapid dissemination of research findings, enabling timely feedback and fostering collaboration within the scientific community.

🛠️ Key Features & Functions

• Rapid Dissemination: Submissions undergo a basic screening process and are typically posted within 48 hours.
• DOI Assignment: Each preprint receives a Digital Object Identifier (DOI), ensuring persistent and citable records.
• Versioning: Authors can upload revised versions of their manuscripts, with all versions accessible and citable.
• Subject Coverage: Accepts preprints across a broad range of health science disciplines.
• Journal Integration: Through the “medRxiv to Journals” (M2J) initiative, authors can directly submit preprints to participating journals.
• Community Feedback: Features a commenting system, allowing readers to provide public feedback.
• Indexing: Preprints are indexed in Crossref, Google Scholar, Europe PMC, and Web of Science’s Preprint Citation Index.

⚖️ Editorial & Ethical Standards

Screening Process: Submissions are reviewed for content appropriateness, plagiarism, and potential public health risks but are not peer-reviewed.

Ethical Compliance: Authors must declare adherence to ethical guidelines, including necessary IRB and/or ethics committee approvals.

Licensing: Authors can choose from various Creative Commons licenses to govern the reuse of their work.

Dual-Use Research: medRxiv screens for content that could potentially endanger public health, including studies describing dual-use research.

💬 User Experience & Community Feedback

Strengths:

• Speed: Enables rapid sharing of research findings, accelerating scientific communication.
• Visibility: High visibility within the health sciences community, with widespread indexing and discoverability.
• Integration: Seamless integration with journal submission processes and community feedback mechanisms.

Criticisms:

• Limited Peer Review: While comments are allowed, the platform does not facilitate formal peer review.
• Variable Feedback: The quality and quantity of community feedback can vary significantly between preprints.

🗣️ Have experience with this platform? Help others decide.

Share your insights in the comments below. Tell us:

• 💲 Cost – Was it truly free? Any hidden charges or integration fees?
• ⏱️ Posting Speed – Was your preprint published quickly after submission
• 🌍 Visibility – Did your preprint gain views, downloads, or media attention
• 🤝 Community Interaction – Did you receive feedback, comments, or engagement
• ⚠️ Concerns – Anything unexpected or frustrating during submission or post-publication?
• ⭐ Your overall rating – Click here to submit

Your feedback helps other researchers make smarter, more confident decisions. Thank you for contributing to a more transparent publishing community!

---

The information presented in this review is compiled from publicly available third-party sources, including the platform’s official website, publisher documentation, and independent directories (e.g., COPE, Crossref, ASAPbio). This review is intended for informational purposes only and does not represent the views or official statements of the platform or its affiliates.

↓ Submit your star rating here